Stock search

Ticker or company name

CVS Health

CVS · NYSE · Health Care

$88,59Down −0,76 (−0,85%)today

Quotes delayed up to 15 min. Updated 16 Nov, 16:00 New York time

Market cap
$114 bn
Div. yield
3,5%
Year to date
+12,6%
52 weeks: $69,51$110,68

Ratio score

83/100
Ratio would consider buying

based on 9 metrics as of 16.11.2026 ·

Verdict by our methodology based on current metrics. Not an investment recommendation.

Key metrics

6 ✓ · 3 — · 0 ✕ · 1 n/a · hover over a row or tap it to see the trend

All metrics

MetricValue5-year medianIndustry median
P/E TTM10,416,725,1
Forward P/E10,7—16,2
PEG1,8—2,2
P/S0,30,32,2
EV/EBITDA10,814,317,3
P/FCF7,3—19,5
P/B1,41,33,4

Industry median — across 33 profitable companies in “Health Care” in Ratio. Revenue and EPS forecasts for future years and the number of employees are in the paid data plan.

Price chart

Compare with

Choose a stock

Closing prices adjusted for splits and dividends. The S&P 500 index and the intraday chart come later.

Analysts

Ratings, 32 analysts

Buy
28
Hold
4
Sell
0

Beat the EPS forecast in 4 of the last 4 quarters

QuarterEstimateActualSurprise
Q3 20261,672,09Up +25,2%
Q2 20261,872,58Up +38,0%
Q1 20262,222,57Up +15,8%
Q4 20251,001,09Up +8,8%

Price targets and yearly revenue and EPS forecasts are in the paid data plan. These are analysts' opinions, not our verdict.

Financials in charts

MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23
Revenue108 bn106 bn100 bn106 bn103 bn98,9 bn94,6 bn97,7 bn95,4 bn91,2 bn88,4 bn93,8 bn
EPS1,682,312,302,32−3,130,801,411,310,071,410,881,59
Margin2,0%2,8%2,9%2,8%−3,9%1,0%1,9%1,7%0,1%1,9%1,3%2,2%
FCF3,91 bn5,65 bn3,40 bn2,61 bn98,0 m1,29 bn3,81 bn1,09 bn−1,42 bn2,45 bn4,20 bn−3,55 bn

From SEC reports. TTM is the sum of 4 quarters; a year is TTM at the end of the calendar year. Forecast bars are in the paid data plan.

Owners

Ownership structure and major holders (13F filings) are in the paid data plan. They are not part of the score or the traffic light.

Insider trades over 12 months

Over 12 months: purchases $2,00 m (1 person), sales $324 m.

NameAmountSharesPrice
shah prem s6 Nov 2026 · open-market purchase$2,00 m23 855$83,90
robbins larry21 May 2026 · sale$34,6 m370 462$93,45
robbins larry20 May 2026 · sale$77 026800$96,28
robbins larry20 May 2026 · sale$6,40 m66 881$95,67
robbins larry20 May 2026 · sale$14,5 m152 691$94,81
robbins larry20 May 2026 · sale$74,6 m797 628$93,48
robbins larry19 May 2026 · sale$14 372151$95,18
robbins larry19 May 2026 · sale$187 m1 983 387$94,45
mandadi tilak8 May 2026 · sale$6,23 m69 551$89,58

SEC Form 4. Titles and trading plans are not in the data. They are not part of the score or the traffic light.

About the company

Industry
Health Care
Exchange
NYSE
Country
US
IPO date
1 Oct 1952

Company description, revenue by segment and region, and the CEO will come later.

Next report
date not announced

An AI summary of the earnings call will come later.

Peers

CompanyPrice
SYKStryker Corporation$310,7272would consider33,0+7,9%13,8%
HCAHCA Healthcare$511,7869would watch15,4+5,8%8,6%
MCKMcKesson$1 105,0472would consider27,3+8,2%1,1%
MDTMedtronic$102,8878would consider25,1+9,8%13,9%
ELVElevance Health$446,2878would consider18,1+3,6%2,5%
Compare with peers

Ratio — a score by our methodology, not an investment recommendation.